Literature DB >> 14732591

Gray and white matter volume abnormalities in monozygotic and same-gender dizygotic twins discordant for schizophrenia.

Hilleke E Hulshoff Pol1, Rachel G H Brans, Neeltje E M van Haren, Hugo G Schnack, Marieke Langen, Wim F C Baaré, Clarine J van Oel, René S Kahn.   

Abstract

BACKGROUND: Whole brain tissue volume decreases in schizophrenia have been related to both genetic risk factors and disease-related (possibly nongenetic) factors; however, whether genetic and environmental risk factors in the brains of patients with schizophrenia are differentially reflected in gray or white matter volume change is not known.
METHODS: Magnetic resonance imaging (1.5 T) brain scans of 11 monozygotic and 11 same-gender dizygotic twin pairs discordant for schizophrenia were acquired and compared with 11 monozygotic and 11 same-gender dizygotic healthy control twin pairs.
RESULTS: Repeated-measures volume analysis of covariance revealed decreased whole brain volume in the patients with schizophrenia as compared with their co-twins and with healthy twin pairs. Decreased white matter volume was found in discordant twin pairs compared with healthy twin pairs, particularly in the monozygotic twin pairs. A decrease in gray matter was found in the patients compared with their co-twins and compared with the healthy twins.
CONCLUSIONS: The results suggest that the decreases in white matter volume reflect the increased genetic risk to develop schizophrenia, whereas the decreases in gray matter volume are related to environmental risk factors. Study of genes involved in the (maintenance) of white matter structures may be particularly fruitful in schizophrenia.

Entities:  

Mesh:

Year:  2004        PMID: 14732591     DOI: 10.1016/s0006-3223(03)00728-5

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  36 in total

1.  White matter volume abnormalities and associations with symptomatology in schizophrenia.

Authors:  Nikolaos Makris; Larry J Seidman; Todd Ahern; David N Kennedy; Verne S Caviness; Ming T Tsuang; Jill M Goldstein
Journal:  Psychiatry Res       Date:  2010-06-09       Impact factor: 3.222

2.  Prefrontal and striatal volumes in monozygotic twins concordant and discordant for schizophrenia.

Authors:  Ulrich Ettinger; Anne Schmechtig; Timothea Toulopoulou; Charmaine Borg; Claire Orrells; Sheena Owens; Kazunori Matsumoto; Neeltje E van Haren; Mei-Hua Hall; Veena Kumari; Philip K McGuire; Robin M Murray; Marco Picchioni
Journal:  Schizophr Bull       Date:  2010-06-10       Impact factor: 9.306

3.  Evidence for white matter abnormalities in schizophrenia.

Authors:  Marek Kubicki; Robert W McCarley; Martha E Shenton
Journal:  Curr Opin Psychiatry       Date:  2005-03       Impact factor: 4.741

Review 4.  Neuroimaging endophenotypes: strategies for finding genes influencing brain structure and function.

Authors:  David C Glahn; Paul M Thompson; John Blangero
Journal:  Hum Brain Mapp       Date:  2007-06       Impact factor: 5.038

Review 5.  Fibroblast growth factors in schizophrenia.

Authors:  Afke F Terwisscha van Scheltinga; Steven C Bakker; René S Kahn
Journal:  Schizophr Bull       Date:  2009-05-08       Impact factor: 9.306

Review 6.  Structural cerebral variations as useful endophenotypes in schizophrenia: do they help construct "extended endophenotypes"?

Authors:  Konasale M Prasad; Matcheri S Keshavan
Journal:  Schizophr Bull       Date:  2008-04-11       Impact factor: 9.306

7.  Functional and anatomical connectivity abnormalities in left inferior frontal gyrus in schizophrenia.

Authors:  Bumseok Jeong; Cynthia G Wible; Ryu-ichiro Hashimoto; Marek Kubicki
Journal:  Hum Brain Mapp       Date:  2009-12       Impact factor: 5.038

8.  Genetic Variation in Schizophrenia Liability is Shared With Intellectual Ability and Brain Structure.

Authors:  Marc M Bohlken; Rachel M Brouwer; René C W Mandl; René S Kahn; Hilleke E Hulshoff Pol
Journal:  Schizophr Bull       Date:  2016-04-07       Impact factor: 9.306

9.  The contribution of neuroimaging to understanding schizophrenia; past, present, and future.

Authors:  Iris E Sommer; René S Kahn
Journal:  Schizophr Bull       Date:  2014-10-27       Impact factor: 9.306

Review 10.  Neurocognitive, Neuroprotective, and Cardiometabolic Effects of Raloxifene: Potential for Improving Therapeutic Outcomes in Schizophrenia.

Authors:  Mohammad M Khan
Journal:  CNS Drugs       Date:  2016-07       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.